KR100223129B1 - 리포좀 제제 - Google Patents

리포좀 제제 Download PDF

Info

Publication number
KR100223129B1
KR100223129B1 KR1019910012144A KR910012144A KR100223129B1 KR 100223129 B1 KR100223129 B1 KR 100223129B1 KR 1019910012144 A KR1019910012144 A KR 1019910012144A KR 910012144 A KR910012144 A KR 910012144A KR 100223129 B1 KR100223129 B1 KR 100223129B1
Authority
KR
South Korea
Prior art keywords
liposomes
aqueous suspension
suspension medium
multiple thin
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019910012144A
Other languages
English (en)
Korean (ko)
Other versions
KR920002165A (ko
Inventor
기쿠치히로시
야치기요토
히로타사다오
Original Assignee
스즈키 다다시
다이이찌 세이야꾸 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스즈키 다다시, 다이이찌 세이야꾸 가부시기가이샤 filed Critical 스즈키 다다시
Publication of KR920002165A publication Critical patent/KR920002165A/ko
Application granted granted Critical
Publication of KR100223129B1 publication Critical patent/KR100223129B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
KR1019910012144A 1990-07-16 1991-07-16 리포좀 제제 Expired - Fee Related KR100223129B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18737090 1990-07-16
JP90-187370 1990-07-16

Publications (2)

Publication Number Publication Date
KR920002165A KR920002165A (ko) 1992-02-28
KR100223129B1 true KR100223129B1 (ko) 1999-10-15

Family

ID=16204819

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910012144A Expired - Fee Related KR100223129B1 (ko) 1990-07-16 1991-07-16 리포좀 제제

Country Status (11)

Country Link
EP (1) EP0467275B1 (enExample)
JP (1) JP2609183B2 (enExample)
KR (1) KR100223129B1 (enExample)
AT (1) ATE144415T1 (enExample)
CA (1) CA2046997C (enExample)
DE (1) DE69122810T2 (enExample)
DK (1) DK0467275T3 (enExample)
ES (1) ES2097168T3 (enExample)
GR (1) GR3021982T3 (enExample)
HU (1) HU211991A9 (enExample)
TW (1) TW205510B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100965088B1 (ko) * 2004-12-07 2010-06-23 (주)아모레퍼시픽 유효성분의 안정화를 위한 다층 라멜라 베지클 및 그제조방법

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2041597B1 (es) * 1992-05-05 1994-06-01 Bazaco Joan Freixas Nuevo procedimiento para la preparacion de liposomas que encapsulan productos farmaceuticos y cosmeticos.
US5464696A (en) * 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
FI961893A0 (fi) * 1993-11-04 1996-05-03 Schering Ag Varautunut liposomivalmiste
DE19639811A1 (de) * 1996-09-27 1998-04-02 Artur Herzog Dr Mesmer Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln
CA2376849C (en) * 1999-06-24 2008-10-14 Kyowa Hakko Kogyo Co., Ltd. Method of inhibiting leakage of drug encapsulated in liposomes
EP1585504A4 (en) * 2002-11-06 2009-07-15 Azaya Therapeutics Inc Protein stabilized liposomal formulations of pharmaceutical active ingredients
GR20060100144A (el) * 2006-03-03 2007-10-17 Θεραπεια του καρκινου με χρηση οξαλιπλατινης εγκλεισμενης μεσα σε λιποσωματα και απο κοινου εγκλεισμος στο λιποσωμιακο μοριο περισσοτερων απο ενος φαρμακευτικου παρασκευασματος h gene
ES2325901B1 (es) * 2008-02-20 2010-07-06 Heber Farma Sl Vehiculizacion del factor de crecimiento epidermico a traves de biomembranas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419348A (en) * 1981-04-27 1983-12-06 Georgetown University Anthracycline glycoside compositions, their use and preparation
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
JPH0617309B2 (ja) * 1985-11-29 1994-03-09 株式会社ビタミン研究所 アドリアマイシン包埋リポソ−ム製剤
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
IL97538A (en) * 1986-12-23 1995-03-15 Liposome Co Inc Multilamellar liposomes containing nonphosphate guanindino aminoglycosides and their preparation.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100965088B1 (ko) * 2004-12-07 2010-06-23 (주)아모레퍼시픽 유효성분의 안정화를 위한 다층 라멜라 베지클 및 그제조방법

Also Published As

Publication number Publication date
CA2046997A1 (en) 1992-01-17
EP0467275A1 (en) 1992-01-22
JP2609183B2 (ja) 1997-05-14
JPH05194191A (ja) 1993-08-03
TW205510B (enExample) 1993-05-11
EP0467275B1 (en) 1996-10-23
DK0467275T3 (enExample) 1997-02-17
DE69122810D1 (de) 1996-11-28
ES2097168T3 (es) 1997-04-01
HU211991A9 (en) 1996-01-29
DE69122810T2 (de) 1997-05-28
ATE144415T1 (de) 1996-11-15
KR920002165A (ko) 1992-02-28
CA2046997C (en) 2000-12-12
GR3021982T3 (en) 1997-03-31

Similar Documents

Publication Publication Date Title
US6060080A (en) Liposomal products
EP0094692B1 (en) Coated ubidecarenone-containing liposome
US5376380A (en) Method of producing liposomal products from freeze or spray-dried preparations of liposomes
US7179484B2 (en) Protein-stabilized liposomal formulations of pharmaceutical agents
EP2450031B1 (en) Method for producing liposomes by two-stage emulsification method using outer aqueous phase containing specific dispersing agent, method for producing liposome dispersion or dry powder thereof using the method for producing liposomes, and liposome dispersion or dry powder thereof produced thereby
JPS63500798A (ja) 改良された取り込み効率を有するマルチラメラリポソ−ム
KR100223129B1 (ko) 리포좀 제제
EP1241172B1 (en) Polyalkylene oxide-modified phospholipid and production method thereof
JPS63112512A (ja) リポソ−ム製剤およびその製造法
EP0883624B1 (de) Tetraetherlipide und diese enthaltende liposomen sowie deren verwendung
JP4480402B2 (ja) リン脂質誘導体
Charumathy et al. Recent update on liposome-based drug delivery system
CN101209348A (zh) 弹性纳米囊泡载体及其制备方法和用途
JP5362998B2 (ja) 乾燥リポソーム製剤
Arndt et al. Antineoplastic activity of sterically stabilized alkylphosphocholine liposomes in human breast carcinomas
CA2513144C (en) Phospholipid derivative and method for producing the same
JP2599390B2 (ja) 安定なリポソーム水分散液
JP2501336B2 (ja) 安定なリポソ−ム製剤
JPH0114A (ja) リポソーム製剤およびその製造法
Dejeu et al. Preparation and characterization of liposomes loaded with polyphenols extracted from callendulae flos.
Ioana et al. Preparation and characterization of liposomes loaded with polyphenols extracted from callendulae Flos.
KR20000032803A (ko) 인체친화적인 리포좀의 제조방법 및 구성성분
JPH013115A (ja) リポソ−ム製剤
JPH0625008A (ja) リピッドａ単糖類縁体含有リポソーム製剤
CN111700823A (zh) 一种聚乙二醇衍生物形成的胶束在化妆品中的用途

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20030618

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20040709

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20040709